CASI - CASI Pharmaceuticals Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript
CASI Pharmaceuticals, Inc. (CASI) Q4 2021 Earnings Conference Call March 28, 2022 08:00 ET Company Participants Wei-Wu He - Chairman and Chief Executive Officer Wei Zhang - President Alex Zukiwski - Chief Medical Officer Jim Goldschmidt - Senior Vice President, Business Development Conference Call Participants Leland Gershell - Oppenheimer Sean Lee - H.C. Wainwright Justin Zelin - BTIG Presentation Operator Good morning and welcome to the CASI Pharmaceuticals Year End 2021 Conference Call. [Operator Instructions] Please note this event is being recorded. I’d now like to turn the conference over to Wei Zhang, Vice President of CASI Pharmaceuticals. Please go ahead. Wei Zhang Thank you, Anthony and good morning everyone. Welcome to CASI’s fourth quarter and year end conference call. Earlier today, CASI issued a press release providing the details of the company’s financial results for the quarter ended December 31, 2021. This press release is available in the Investors
For further details see:
CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript